Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1990 1
1993 1
1995 1
1996 1
1999 1
2001 1
2002 2
2003 1
2004 1
2005 1
2006 1
2009 2
2010 2
2015 2
2016 1
2018 1
2019 3
2020 1
2021 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hypopigmentation of the fundus"
Page 1
Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Daniel E, Ying GS, Kim BJ, Toth CA, Ferris F 3rd, Martin DF, Grunwald JE, Jaffe GJ, Dunaief JL, Pan W, Maguire MG; Comparison of Age-Related Macular Degeneration Treatments Trials. Daniel E, et al. Ophthalmology. 2019 May;126(5):743-751. doi: 10.1016/j.ophtha.2018.11.020. Epub 2018 Nov 23. Ophthalmology. 2019. PMID: 30476517 Free PMC article. Clinical Trial.
PURPOSE: To describe changes in visual acuity (VA) and macular morphologic features at 5 years in eyes with nonfibrotic scar (NFS) identified at 1 year in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). DESIGN: Prospective cohort study within a ran …
PURPOSE: To describe changes in visual acuity (VA) and macular morphologic features at 5 years in eyes with nonfibrotic scar (NFS) identifie …
A novel GPR143 mutation in a Chinese family with X‑linked ocular albinism type 1.
Gao X, Liu T, Cheng X, Dai A, Liu W, Li R, Zhang M. Gao X, et al. Mol Med Rep. 2020 Jan;21(1):240-248. doi: 10.3892/mmr.2019.10813. Epub 2019 Nov 12. Mol Med Rep. 2020. PMID: 31746431 Free PMC article. Clinical Trial.
A total of 18 family members (nine affected patients and nine normal subjects) from Hainan, China, were recruited to the present study in December 2017. A detailed clinical ophthalmic examination was performed for all participants, including a visual acuity test, anterior …
A total of 18 family members (nine affected patients and nine normal subjects) from Hainan, China, were recruited to the present study in De …
Management of aggressive posterior retinopathy of prematurity in oculocutaneous albinism.
Panchal B, Gulati M. Panchal B, et al. BMJ Case Rep. 2021 Feb 1;14(2):e238490. doi: 10.1136/bcr-2020-238490. BMJ Case Rep. 2021. PMID: 33526528 Free PMC article.
A male infant, born preterm at 32 weeks of gestation, was referred at 36-week postmenstrual age for retinopathy of prematurity (ROP) screening. He had nystagmus, generalised hypopigmentation of skin, hair and eyes with preaxial polydactyly. The fundus was depigmente …
A male infant, born preterm at 32 weeks of gestation, was referred at 36-week postmenstrual age for retinopathy of prematurity (ROP) screeni …
Adaptive optics retinal imaging: emerging clinical applications.
Godara P, Dubis AM, Roorda A, Duncan JL, Carroll J. Godara P, et al. Optom Vis Sci. 2010 Dec;87(12):930-41. doi: 10.1097/OPX.0b013e3181ff9a8b. Optom Vis Sci. 2010. PMID: 21057346 Free PMC article.
Here, we review some of the advances that were made possible with AO imaging of the human retina and discuss applications and future prospects for clinical imaging....
Here, we review some of the advances that were made possible with AO imaging of the human retina and discuss applications and future prospec …
Inter- and intra-observer variability in grading lesions of age-related maculopathy and macular degeneration.
Scholl HP, Peto T, Dandekar S, Bunce C, Xing W, Jenkins S, Bird AC. Scholl HP, et al. Graefes Arch Clin Exp Ophthalmol. 2003 Jan;241(1):39-47. doi: 10.1007/s00417-002-0602-8. Epub 2002 Dec 18. Graefes Arch Clin Exp Ophthalmol. 2003. PMID: 12545291
METHODS: Fifty eyes of 25 patients with ARM or AMD in at least one eye were randomly selected from a large ongoing collection of clinical data and DNA in a tertiary referral UK population. Stereoscopic color fundus photographs were taken with a 30 degrees …
METHODS: Fifty eyes of 25 patients with ARM or AMD in at least one eye were randomly selected from a large ongoing collection of c …
INADVERTENT GLOBE PENETRATION AND SUBRETINAL INJECTION OF BOTULINUM TOXIN IN A PATIENT WITH OCULOCUTANEOUS ALBINISM.
Aljohani S, AlJaloud A, Alsakran WA, AlZaid A. Aljohani S, et al. Retin Cases Brief Rep. 2023 May 1;17(3):302-304. doi: 10.1097/ICB.0000000000001160. Retin Cases Brief Rep. 2023. PMID: 34001765
METHODS: Botulinum toxin A injection was administered to a 5-year-old patient with oculocutaneous albinism with esotropia and resulted in an ocular penetration. Dilated fundus examination indicated a nasal retinal tear causing a mild vitreous hemorrhage and a localized ret …
METHODS: Botulinum toxin A injection was administered to a 5-year-old patient with oculocutaneous albinism with esotropia and resulted in an …
Screening of Glaucoma or Cataract Prevalence in Vitiligo Patients and Its Relationship With Periorbital Steroid Use.
Khurrum H, AlGhamdi KM, Osman E. Khurrum H, et al. J Cutan Med Surg. 2016 Mar-Apr;20(2):146-9. doi: 10.1177/1203475415615325. Epub 2015 Oct 27. J Cutan Med Surg. 2016. PMID: 26506954
In contrast, glaucoma was not observed in 79% (71/90) of the vitiligo patients who did not use steroids. Cataract, uveitis, or fundus problems were not observed in either group. CONCLUSION: The study suggests that patients who have vitiligo and use topical steroids periorb …
In contrast, glaucoma was not observed in 79% (71/90) of the vitiligo patients who did not use steroids. Cataract, uveitis, or fundus …
The VECAT study: methodology and statistical power for measurement of age-related macular features. Vitamin E, Cataract, and Age-related Maculopathy Study.
Tikellis G, Robman LD, Harper CA, Garrett SK, McNeil JJ, Taylor HR, McCarty CA. Tikellis G, et al. Ophthalmic Epidemiol. 1999 Sep;6(3):181-94. doi: 10.1076/opep.6.3.181.1502. Ophthalmic Epidemiol. 1999. PMID: 10487973 Clinical Trial.
METHODS: The 1204 participants enrolled in the Vitamin E, Cataract, and Age-related Maculopathy Study (VECAT) had colour stereoslides of their fundus taken using the Nidek 3-DX mydriatic fundus camera. The stereoslides were graded by two masked graders according to …
METHODS: The 1204 participants enrolled in the Vitamin E, Cataract, and Age-related Maculopathy Study (VECAT) had colour stereoslides of the …
5-year incidence of age-related maculopathy in the Reykjavik Eye Study.
Jonasson F, Arnarsson A, Peto T, Sasaki H, Sasaki K, Bird AC. Jonasson F, et al. Ophthalmology. 2005 Jan;112(1):132-8. doi: 10.1016/j.ophtha.2004.07.020. Ophthalmology. 2005. PMID: 15629833
DESIGN: Population-based, prospective cohort study. PARTICIPANTS: The cohort was a population-based random sample of citizens 50 years and older. Of 1379 eligible subjects, 1045 had a baseline examination in 1996; 846 of the 958 survivors (88.2%) had a 5-year follow-up exa …
DESIGN: Population-based, prospective cohort study. PARTICIPANTS: The cohort was a population-based random sample of citizens 50 year …
25 results